Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator

ABSTRACT: Generic versions of intravenous antibiotics are not required to demonstrate therapeutic equivalence with the innovator because therapeutic equivalence is assumed from pharmaceutical equivalence. To test such assump tions, we studied three generic versions of vancomycin in simultaneous expe...

Full description

Autores:

Agudelo García, Olga María
Salazar Giraldo, Beatriz
Rodríguez Jaramillo, Carlos Andrés
Zuluaga Salazar, Andrés Felipe
Vesga Meneses, Omar

Tipo de recurso:

Article of investigation

Fecha de publicación:

2010

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/43569

Acceso en línea:

https://hdl.handle.net/10495/43569

Palabra clave:

Medicamentos Genéricos
Drugs, Generic
Pruebas de Sensibilidad Microbiana
Microbial Sensitivity Tests
Neutropenia
Neutropenia
Infecciones Estafilocócicas
Staphylococcal Infections
Equivalencia Terapéutica
Therapeutic Equivalency
Insuficiencia del Tratamiento
Treatment Failure
Vancomicina
Vancomycin
Antibacterianos
Anti-Bacterial Agents
https://id.nlm.nih.gov/mesh/D016568
https://id.nlm.nih.gov/mesh/D008826
https://id.nlm.nih.gov/mesh/D009503
https://id.nlm.nih.gov/mesh/D013203
https://id.nlm.nih.gov/mesh/D013810
https://id.nlm.nih.gov/mesh/D017211
https://id.nlm.nih.gov/mesh/D014640
https://id.nlm.nih.gov/mesh/D000900

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/